Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,490,765
-$367,275 QoQ
Shares Held
57,057
-6.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
#905
of 4,664 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arvest Bank Trust Division holds $45,815,739 across 8 Drug Manufacturers - General names. JNJ ranks #2 (31.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
60,049 | $15,110,729 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
57,057 | $14,490,765 | |
| 3 | LLY |
ELI LILLY & Co
|
9,403 | $11,278,240 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,386 | $1,848,601 | |
| 5 | PFE |
Pfizer Inc
|
48,596 | $1,170,191 | |
| 6 | NVS |
Novartis AG
|
5,844 | $915,871 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,969 | $747,273 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,011 | $254,069 |
All Filings in JNJ
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,490,765 | 57,057 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $14,858,040 | 60,784 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $15,862,924 | 76,651 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $14,772,225 | 79,669 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $12,459,817 | 81,570 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $14,167,710 | 85,430 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $12,608,694 | 87,185 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,340,689 | 88,490 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $20,184,108 | 124,979 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $20,920,496 | 126,991 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $20,908,442 | 127,219 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $20,256,536 | 128,711 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $19,024,481 | 127,784 | Shares | Sole | 2020-11-30 | |
| 2020-06-30 | $18,537,987 | 131,821 | Shares | Sole | 2020-08-21 | |
| 2020-03-31 | $17,397,934 | 132,677 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||